Valeant Pharma (VRX) Shares Remain Volatile as Chatter Continues

November 2, 2016 3:13 PM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Valeant Pharma (NYSE: VRX) shares are active again following news that the company might sell its eye-surgery equipment unit.

The stock is down around 10 percent, following a 33.7 percent gain on Monday and 12.4 percent drop last Friday. That would mean three sessions of double-digit moves.

Notably, short interest recently rose to 30.65 million shares, or 9 percent of float, as of mid-October.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Rumors, Short Sales, Trader Talk

Add Your Comment